Manhasset, NY – Two Feinstein Institute for Medical Research scientists have each been awarded five-year grants – one for 3 million and another 2 million – from the National Institutes of Health (NIH). Kevin J. Tracey, MD, Feinstein Institute president and CEO, and Ping Wang, MD, chief scientific officer, have each received this distinguished honor to continue… read more
Manhasset, NY – The Feinstein Institute for Medical Research President and CEO Kevin J. Tracey, MD will be awarded the Scientific Achievement Award at the 39th Annual Conference on Shock during a dinner ceremony today. The Shock Society award, which recognizes lifetime achievements in the field of shock research, is being presented to Dr. Tracey for his… read more
Manhasset, NY – Feinstein Institute for Medical Research and TheraSource LLC, a Long Island-based biotech company, announced today that TheraSource has received a $3 million three-year Small Business Innovation Research (SBIR) grant from the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The grant will support the development… read more
MANHASSET, NY – The Feinstein Institute for Medical Research today announced the appointment of two new members to its Board of Directors, David Dangoor and Scott Rechler. “The addition of David Dangoor and Scott Rechler strengthens our already-impressive and dedicated group of board members,” said Board Chair Barbara Hrbek Zucker. “As a board, we will continue to… read more
Kevin J. Tracey, MD, president and CEO of The Feinstein Institute for Medical Research, was honored with a Sepsis Heroes Award by the Sepsis Alliance, a patient advocacy group, in recognition for his leadership role in improving understanding of sepsis. Click here to read about our initiatives in sepsis.
Promising profile of disease modification and pain reduction leads to proof of concept trials Manhasset, NY – Molecular Medicine, a peer-reviewed biomedical journal published by the Feinstein Institute Press, published the results of a new study reporting clinically significant pain reduction in type 2 diabetic patients. In an exploratory study conducted by Araim Pharmaceuticals, a biotech… read more